Diacerein Alone and in Combination with Infliximab Suppresses the Combined Proinflammatory Effects of IL-17A, IL-22, Oncostatin M, IL-1A, and TNF-alpha in Keratinocytes: A Potential Therapeutic Option in Psoriasis.

C. Doo,Lei Bao,Kui Shen,Jessica F. Yang,Rachel R Shen,Lawrence S. Chan

Diacerein Alone and in Combination with Infliximab Suppresses the Combined Proinflammatory Effects of IL-17A, IL-22, Oncostatin M, IL-1A, and TNF-alpha in Keratinocytes: A Potential Therapeutic Option in Psoriasis.

2021

C. Doo
Lei Bao
Kui Shen
Jessica F. Yang
Rachel R Shen
Lawrence S. Chan

Psoriasis is a chronic disorder characterized by a complex interplay between keratinocytes and inflammatory mediators. In a previous study, we evaluated diacerein's ability to diminish interleukin ...

Keywords:

Tumor necrosis factor alpha
Diacerein
Psoriasis
Immunology
Proinflammatory cytokine
Interleukin 22
Medicine
Interleukin
Infliximab
Oncostatin M

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations